221 related articles for article (PubMed ID: 15450887)
1. Medical management of skeletal metastasis.
Yu MK; Buys SS
Neurosurg Clin N Am; 2004 Oct; 15(4):529-36, xi. PubMed ID: 15450887
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates--role in cancer therapies.
Mehrotra B
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
[No Abstract] [Full Text] [Related]
3. Evaluating bone metastases.
Albert K
Clin J Oncol Nurs; 2007 Apr; 11(2):193-7. PubMed ID: 17573268
[No Abstract] [Full Text] [Related]
4. [Clinical analysis of 355 patients with bone metastasis of malignant tumors].
Liu NN; Shen DL; Chen XQ; He YL
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):203-7. PubMed ID: 20450589
[TBL] [Abstract][Full Text] [Related]
5. Bone metastases: Part I--Pathophysiology.
Fisher G; Mayer DK; Struthers C
Clin J Oncol Nurs; 1997 Apr; 1(2):29-35. PubMed ID: 9410649
[TBL] [Abstract][Full Text] [Related]
6. Bone metastases in breast cancer, prostate cancer and myeloma.
Paterson AH
Bone; 1987; 8 Suppl 1():S17-22. PubMed ID: 3318889
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates: clinical experience.
Coleman RE
Oncologist; 2004; 9 Suppl 4():14-27. PubMed ID: 15459426
[TBL] [Abstract][Full Text] [Related]
8. [Bisphosphonates in the therapy of cancer patients].
Jantunen E; Kumpulainen E
Duodecim; 1999; 115(1):27-32. PubMed ID: 11830857
[No Abstract] [Full Text] [Related]
9. [Physiopathology, diagnosis and management of bone metastases from prostate cancer].
Lebret T; Méjean A
Prog Urol; 2008 Nov; 18 Suppl 7():S349-56. PubMed ID: 19070815
[TBL] [Abstract][Full Text] [Related]
10. [Symptom with bone metastasis--bone pain, fracture, hypercalcemia].
Toyoshi H
Nihon Rinsho; 2007 Jan; 65(1):76-81. PubMed ID: 17233419
[TBL] [Abstract][Full Text] [Related]
11. Metastatic bone disease: general principles, pathophysiology, evaluation, and biopsy.
Frassica FJ; Gitelis S; Sim FH
Instr Course Lect; 1992; 41():293-300. PubMed ID: 1588070
[No Abstract] [Full Text] [Related]
12. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
Kanakis I; Kousidou OCh; Karamanos NK
In Vivo; 2005; 19(1):311-8. PubMed ID: 15796191
[TBL] [Abstract][Full Text] [Related]
13. Local effects of malignancy on bone.
Brown SA; Clines GA; Guise TA
Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):436-41. PubMed ID: 17982348
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features of pathologically confirmed metastatic bone tumors--a report of 390 cases].
Xu DL; Zhang XT; Wang GH; Li FB; Hu JY
Ai Zheng; 2005 Nov; 24(11):1404-7. PubMed ID: 16552972
[TBL] [Abstract][Full Text] [Related]
15. [Management of bone metastases].
Nagykálnai T; Landherr L
Orv Hetil; 2014 Feb; 155(6):217-25. PubMed ID: 24486845
[TBL] [Abstract][Full Text] [Related]
16. [Differential diagnosis and therapy of tumor-associated hypercalcemia].
Thomas M; Schneider W
Dtsch Med Wochenschr; 1989 Oct; 114(41):1576-81. PubMed ID: 2680409
[No Abstract] [Full Text] [Related]
17. Approaches to managing bone metastases from breast cancer: the role of bisphosphonates.
Mystakidou K; Katsouda E; Stathopoulou E; Vlahos L
Cancer Treat Rev; 2005 Jun; 31(4):303-11. PubMed ID: 16039956
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates and bone metastases: current status and future directions.
Krempien R; Niethammer A; Harms W; Debus J
Expert Rev Anticancer Ther; 2005 Apr; 5(2):295-305. PubMed ID: 15877526
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of bone metastases in breast cancer patients.
Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M
Expert Opin Pharmacother; 2008 Apr; 9(6):937-45. PubMed ID: 18377337
[TBL] [Abstract][Full Text] [Related]
20. [Scintigraphy with strontium 85 in bone metastases].
Bessler W
Fortschr Geb Rontgenstr Nuklearmed; 1967 Jan; 106(1):43-51. PubMed ID: 6067816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
